يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"AND EQUIPMENT::Investigative Techniques::Evaluation Studies as Topic::Product Surveillance"', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Institut Català de la Salut, Agustí A Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Cereza G Catalan Centre of Pharmacovigilance. Directorate-General for Healthcare Planning and Regulation, Ministry of Health, Government of Catalonia, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. de Abajo FJ Department of Biomedical Sciences, University of Alcalá (IRYCIS) and Unit of Clinical Pharmacology, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. Maciá MA Division of Pharmacoepidemology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices, Spain. Sacristán JA Medical Department, Lilly Spain, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Pharmacological Research;197; https://doi.org/10.1016/j.phrs.2023.106967; Agustí A, Cereza G, de Abajo FJ, Maciá MA, Sacristán JA. Clinical pharmacology facing the real-world setting: pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs. Pharmacol Res. 2023 Nov;197:106967.; https://hdl.handle.net/11351/10640

  2. 2
    Academic Journal

    المساهمون: Institut Català de la Salut, Sancho-López A, Ruiz-Antorán B, Ramírez-García A Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain. Iglesias Hernangómez T Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain. Gómez-Estévez I Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. Department of Medicine, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain. Sanabria-Cabrera J Clinical Pharmacology Department, Hospital Universitario Virgen de la Victoria, IBIMA_Plataforma BIONAND, Universidad de Málaga, Malaga, Spain. Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain. Bosch Ferrer M Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Farmacologia Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;12(20); https://doi.org/10.3390/jcm12206471; Sancho-López A, Ruiz-Antorán B, Iglesias Hernangómez T, Ramírez-García A, Gómez-Estévez I, Sanabria-Cabrera J, et al. The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study). J Clin Med. 2023 Oct 11;12(20):6471.; https://hdl.handle.net/11351/10590

  3. 3
    Academic Journal

    المساهمون: Institut Català de la Salut, Dos Santos G GSK, Wavre, Belgium. Wang H GSK, Amsterdam, The Netherlands. Jindal P Parexel International, Chandigarh, India, C/O GSK, Rockville, MD, USA. Rybo M PPD, Sundbyberg, Sweden. Roul H Keyrus Life Science, Levallois-Perret, France, C/O GSK, Wavre, Belgium. Pallem S Keyrus Life Science, New York, NY, USA, C/O GSK, New York, NY, USA. Martínez Gómez X Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Infectious Diseases and Therapy;11; https://doi.org/10.1007/s40121-021-00571-y; Dos Santos G, Wang H, Jindal P, Rybo M, Roul H, Pallem S, et al. Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season. Infect Dis Ther. 2022 Feb;11:463–83.; https://hdl.handle.net/11351/8636; 000735967500001

  4. 4
    Academic Journal

    المساهمون: Institut Català de la Salut, Aguilera C, Agustí A, Diogène E, Danés I Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup de Recerca en Malalties Immunomediades i Teràpies Innovadores, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Pérez E Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Gracia RM Unitat de Cures Intensives, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;10(15); https://doi.org/10.3390/jcm10153293; Aguilera C, Agustí A, Pérez E, Gracia RM, Diogène E, Danés I. Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study. J Clin Med. 2021 Aug;10(15):3293.; https://hdl.handle.net/11351/7343; 000682062700001

  5. 5
    Book

    وصف الملف: 1 disco compacto (CDROM); 12 cm; application/pdf

    Relation: http://www.juntadeandalucia.es/salud/absys/documento/p_quimicos.pdf; Tarancón Estrada M, Gallego Quevedo MT, Marchena Fernández FJ. Productos químicos : peligrosidad y control del riesgo sanitario. Sevilla : Consejería de Salud, 2003; WA 465; http://hdl.handle.net/10668/1245; SE-3373-03

  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Suzuki,A Division of Gastroenterology, Duke University, Durham, North Carolina, USA. Andrade Bellido,RJ Unidad de Hepatología (Hepatology Unit), Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Coordinating Center, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Campus Universitario de Teatinos, Malaga, Spain. Bjornsson,E Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland. Andrade Bellido,RJ, Lucena González,MI Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Málaga, Spain. Lucena González,MI Servicio de Farmacología Clínica (Clinical Pharmacology Service), Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Coordinating Center, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Campus Universitario de Teatinos, Málaga, Spain. Lee,WM Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA. Yuen,NA, Hunt,CM Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Durham, North Carolina, USA. Freston,JW Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA., This study has been partially funded by a research grant from the Spanish Medicine Agency, Fondo de Investigacion Sanitaria FIS PI 07/0980 and EC07/90910, and received support from Boehringer-Ingelheim. CIBERehd is funded by Instituto de Salud Carlos III. The ALF Study Group is funded by NIH Grant U-01 DK058369.

    وصف الملف: application/pdf

    Relation: http://adisonline.com/drugsafety/pages/articleviewer.aspx?year=2010&issue=33060&article=00007&type=abstract; Suzuki A, Andrade RJ, Bjornsson E, Lucena MI, Lee WM, Yuen NA, et al. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf. 2010; 33(6):503-22; http://hdl.handle.net/10668/588

  8. 8
  9. 9

    المساهمون: [Suzuki,A] Division of Gastroenterology, Duke University, Durham, North Carolina, USA. [Andrade Bellido,RJ] Unidad de Hepatología (Hepatology Unit), Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Coordinating Center, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Campus Universitario de Teatinos, Malaga, Spain. [Bjornsson,E] Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland. [Andrade Bellido,RJ, Lucena González,MI] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Málaga, Spain. [Lucena González,MI] Servicio de Farmacología Clínica (Clinical Pharmacology Service), Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Coordinating Center, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Campus Universitario de Teatinos, Málaga, Spain. [Lee,WM] Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA. [Yuen,NA, Hunt,CM] Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Durham, North Carolina, USA. [Freston,JW] Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA., This study has been partially funded by a research grant from the Spanish Medicine Agency, Fondo de Investigacion Sanitaria FIS PI 07/0980 and EC07/90910, and received support from Boehringer-Ingelheim. CIBERehd is funded by Instituto de Salud Carlos III. The ALF Study Group is funded by NIH Grant U-01 DK058369.

    مصطلحات موضوعية: Liver damage, medicine.medical_specialty, Prescription Drugs, Toxicidad de Medicamentos, International Cooperation, Pharmacology toxicology, MEDLINE, Postmarketing surveillance, Toxicology, World Health Organization, Chemicals and Drugs::Pharmaceutical Preparations::Prescription Drugs [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Safety-Based Drug Withdrawals, Disciplines and Occupations::Social Sciences::Internationality::International Cooperation [Medical Subject Headings], Pharmacovigilance, Medicine, Adverse Drug Reaction Reporting Systems, Humans, Pharmacology (medical), Adverse effect, Intensive care medicine, Pharmacology, Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings], Extramural, business.industry, Diseases::Substance-Related Disorders::Poisoning::Drug-Induced Liver Injury [Medical Subject Headings], Geographicals::Geographic Locations::Europe [Medical Subject Headings], United States, Surgery, Europe, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Product Surveillance, Postmarketing::Adverse Drug Reaction Reporting Systems [Medical Subject Headings], Clinical diagnosis, Health Care::Health Services Administration::Organization and Administration::Pharmacy Administration::Drug and Narcotic Control [Medical Subject Headings], Drug and Narcotic Control, Chemical and Drug Induced Liver Injury, Health Care::Health Services Administration::Organization and Administration::Pharmacy Administration::Drug and Narcotic Control::Safety-Based Drug Withdrawals [Medical Subject Headings], business, Geographicals::Geographic Locations::Americas::North America::United States [Medical Subject Headings]

    وصف الملف: application/pdf